Research LettersNeonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic
References (5)
- et al.
Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery
Lancet
(1997) - et al.
Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term
Am J Obstet Gynecol
(1995)
There are more references available in the full text version of this article.
Cited by (106)
Acute Kidney Injury and Chronic Kidney Disease
2018, Avery's Diseases of the Newborn: Tenth EditionAcute Kidney Injury and Chronic Kidney Disease
2017, Avery's Diseases of the Newborn, Tenth EditionDevelopment and Regulation of Renal Blood Flow in the Neonate
2017, Fetal and Neonatal Physiology, 2-Volume SetAnalgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications
2015, Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment: Third EditionPostnatal Maturation of Renal Blood Flow
2011, Fetal and Neonatal Physiology E-Book, Fourth EditionIndometacin: Come back of a controversial tocolytic? Obstetrical point of view
2010, Archives de Pediatrie
Copyright © 1999 Elsevier Ltd. All rights reserved.